US Patent Issued to Centro de Inmunologia Molecular on April 22 for "Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines" (Cuban Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,109, issued on April 22, was assigned to Centro de Inmunologia Molecular (Havana).

"Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines" was invented by Luis Enrique Fernandez Molina (Havana), Belinda Sanchez Ramirez (Havana), Audry Fernandez Gomez (Havana), Gretchen Bergado Baez (Havana), Circe Mesa Pardillo (Havana), Lisset Chao Garcia (Sancti Spiritus, Cuba), Narjara Gonzalez Suarez (Havana), Dayana Perez Martinez (Havana), Diana Rosa Hernandez Fernandez (Havana), Mabel Cruz Rodriguez (Havana), Angel Alexis Manso Vargas (Havana), Vicente Guillermo Verez Bencomo (Havana), Blanca Idelmis Tolon Murguia (Havana), Miguel Antonio Lopez Lopez (Hav...